SOLICITATION NOTICE
B -- Customized Biological Services
- Notice Date
- 9/3/2019
- Notice Type
- Presolicitation
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB, 5601 Fishers Lane, 3rd Floor MSC 9822, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- NIAID-NOI19-1973677
- Archive Date
- 9/21/2019
- Point of Contact
- Julie Yun, Phone: 2406273734
- E-Mail Address
-
julie.yun@nih.gov
(julie.yun@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- This is a Pre-solicitation Notice, not a request for quotations (RFQ). The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Genscript USA Incorporated to procure customized biological services. The purpose of this acquisition is to acquire customized biological services that include without limitation to CloneArk plasmid preparation, plasmid sequencing and production, protein production/purification, protein expression, customized MaMPilot rAb expression, gene to antibody expression and other customized services. The Biodefense Research Section of the Vaccine Research Center (VRC) at NIAID develops vaccines and monoclonal antibody therapies for the treatment of biodefense related pathogens. The requested biological services will provide reagents and material end products that will be used for the development and testing of therapeutic antibody and vaccine candidates. As part of an existing study, Genscript has previously produced plasmids, DNA synthesis with cloning, customized VRC DNA vectors, and sequence verification with additional quality controls for the VRC. These biological services being requested require highly customized protocols and quality control protocols to be performed. To maintain data integrity, prevent data variability and to prevent alteration of customized protocols, Genscript must continue to provide these services to the Biodefense Research Section. Changing protocols, at this time, will lead to variations in the final product and the research data. The statutory authority for this sole source requirement is 41 U.S.C. 253(c)(1) as implemented by FAR 6. 302-1 only one responsible source and no other supply or service will satisfy agency requirements. THIS IS NOT A REQUEST FOR QUOTATIONS (RFQ). All responsible sources may submit a capability statement that will be considered by email (subject line to reference NIAID-NOI19-1973677) to Julie Yun at julie.yun@nih.gov by 12:00PM EST September 6, 2019. Responses received by the closing date of this Notice will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. SPECIAL NOTICE Offerors are advised that the Government may share your information with non-government personnel who are assisting with the evaluation of responses. The exclusive responsibility for source selection will reside with the Government. By submitting your response, you will be consenting to disclosure of your offer to non-government personnel for purposes of evaluation.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/AMOB/NIAID-NOI19-1973677/listing.html)
- Place of Performance
- Address: Vaccine Research Center 40 Convent Drive, Bethesda, Maryland, 20814, United States
- Zip Code: 20814
- Zip Code: 20814
- Record
- SN05428804-W 20190905/190903231206-a3260e1a3f8b3cb2559889f7f2b9962f (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |